Molina Healthcare, Inc (NYSE:MOH) Receives $207.06 Average Price Target from Brokerages

Shares of Molina Healthcare, Inc (NYSE:MOH) have been assigned a consensus recommendation of “Hold” from the seventeen ratings firms that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $202.4375.

Several research analysts have recently issued reports on the stock. Barclays lowered their target price on shares of Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating for the company in a report on Friday. Weiss Ratings cut shares of Molina Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday. Zacks Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 23rd. JPMorgan Chase & Co. upped their price objective on shares of Molina Healthcare from $169.00 to $191.00 and gave the company a “neutral” rating in a research note on Monday, June 8th. Finally, Truist Financial dropped their price objective on Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a report on Friday, July 24th.

Molina Healthcare Price Performance

Shares of MOH opened at $200.88 on Friday. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $244.89. The stock has a market cap of $10.49 billion, a PE ratio of -1,115.92, a P/E/G ratio of 28.54 and a beta of 0.74. The firm has a 50-day simple moving average of $206.81 and a two-hundred day simple moving average of $177.25. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping the consensus estimate of $1.39 by $0.12. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The business had revenue of $10.87 billion during the quarter, compared to the consensus estimate of $10.83 billion. During the same quarter in the previous year, the firm posted $5.48 earnings per share. The company’s quarterly revenue was down 4.8% compared to the same quarter last year. As a group, analysts forecast that Molina Healthcare will post 5.3 EPS for the current year.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This represents a 4.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the sale, the insider owned 67,175 shares of the company’s stock, valued at $12,502,611. This trade represents a 20.96% decrease in their position. The SEC filing for this sale provides additional information. 1.44% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. ARGA Investment Management LP increased its stake in shares of Molina Healthcare by 1.4% in the 1st quarter. ARGA Investment Management LP now owns 4,166 shares of the company’s stock valued at $555,000 after buying an additional 59 shares during the period. Blue Trust Inc. lifted its stake in shares of Molina Healthcare by 23.8% during the fourth quarter. Blue Trust Inc. now owns 322 shares of the company’s stock valued at $56,000 after acquiring an additional 62 shares during the period. Elevation Wealth Partners LLC boosted its holdings in Molina Healthcare by 118.2% in the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock valued at $33,000 after acquiring an additional 78 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in Molina Healthcare by 64.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 232 shares of the company’s stock valued at $40,000 after acquiring an additional 91 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in Molina Healthcare by 0.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,668 shares of the company’s stock worth $2,616,000 after purchasing an additional 92 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.